|
1
|
Ma L, Wang B, Long Y and Li H: Effect of
traditional Chinese medicine combined with Western therapy on
primary hepatic carcinoma: A systematic review with meta-analysis.
Front Med. 11:191–202. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wu X, Li J, Wang C, Zhang G, Zheng N and
Wang X: Application of different imaging methods in the early
diagnosis of primary hepatic carcinoma. Gastroenterol Res Pract.
2016:87632052016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Berretta M, Cavaliere C, Alessandrini L,
Stanzione B, Facchini G, Balestreri L, Perin T and Canzonieri V:
Serum and tissue markers in hepatocellular carcinoma and
cholangiocarcinoma: Clinical and prognostic implications.
Oncotarget. 8:14192–14220. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Peng L, Chen G, Zhu Z, Shen Z, Du C, Zang
R, Su Y, Xie H, Li H, Xu X, et al: Circular RNA ZNF609 functions as
a competitive endogenous RNA to regulate AKT3 expression by
sponging miR-150-5p in Hirschsprung's disease. Oncotarget.
8:808–818. 2017.PubMed/NCBI
|
|
6
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Salzman J: Circular RNA Expression: Its
potential regulation and function. Trends Genet. 32:309–316. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Memczak S, Papavasileiou P, Peters O and
Rajewsky N: Identification and characterization of circular RNAs as
a new class of putative biomarkers in human blood. PLoS One.
10:e1412142015. View Article : Google Scholar
|
|
9
|
Li F, Zhang L, Li W, Deng J, Zheng J, An
M, Lu J and Zhou Y: Circular RNA ITCH has inhibitory effect on ESCC
by suppressing the Wnt/β-catenin pathway. Oncotarget. 6:6001–6013.
2015.PubMed/NCBI
|
|
10
|
Liu Y, Cui H, Wang W, Li L, Wang Z, Yang S
and Zhang X: Construction of circular miRNA sponges targeting
miR-21 or miR-221 and demonstration of their excellent anticancer
effects on malignant melanoma cells. Int J Biochem Cell Biol.
45:2643–2650. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sand M, Bechara FG, Sand D, Gambichler T,
Hahn SA, Bromba M, Stockfleth E and Hessam S: Circular RNA
expression in basal cell carcinoma. Epigenomics. 8:619–632. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang C, Wu H, Wang Y, Zhao Y, Fang X,
Chen C and Chen H: Expression patterns of circular RNAs from
primary kinase transcripts in the mammary glands of lactating rats.
J Breast Cancer. 18:235–241. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bachmayr-Heyda A, Reiner AT, Auer K,
Sukhbaatar N, Aust S, Bachleitner-Hofmann T, Mesteri I, Grunt TW,
Zeillinger R and Pils D: Correlation of circular RNA abundance with
proliferation-Exemplified with colorectal and ovarian cancer,
idiopathic lung fibrosis, and normal human tissues. Sci Rep.
5:80572015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li P, Chen S, Chen H, Mo X, Li T, Shao Y,
Xiao B and Guo J: Using circular RNA as a novel type of biomarker
in the screening of gastric cancer. Clin Chim Acta. 444:132–136.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qu S, Song W, Yang X, Wang J, Zhang R,
Zhang Z, Zhang H and Li H: Microarray expression profile of
circular RNAs in human pancreatic ductal adenocarcinoma. Genomics
Data. 5:385–387. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J,
Chen D, Gu J, He X and Huang S: Circular RNA is enriched and stable
in exosomes: A promising biomarker for cancer diagnosis. Cell Res.
25:981–984. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qin M, Liu G, Huo X, Tao X, Sun X, Ge Z,
Yang J, Fan J, Liu L and Qin W: Hsa_circ_0001649: A circular RNA
and potential novel biomarker for hepatocellular carcinoma. Cancer
Biomark. 16:161–169. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shang X, Li G, Liu H, Li T, Liu J, Zhao Q
and Wang C: Comprehensive circular RNA profiling reveals that
hsa_circ_0005075, a new circular RNA biomarker, is involved in
hepatocellular carcinoma development. Medicine (Baltimore).
95:e38112016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang XY, Huang ZL, Xu YH, Zheng Q, Chen
Z, Song W, Zhou J, Tang ZY and Huang XY: Comprehensive circular RNA
profiling reveals the regulatory role of the
circRNA-100338/miR-141-3p pathway in hepatitis B-related
hepatocellular carcinoma. Sci Rep. 7:54282017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fu L, Yao T, Chen Q, Mo X, Hu Y and Guo J:
Screening differential circular RNA expression profiles reveals
hsa_circ_0004018 is associated with hepatocellular carcinoma.
Oncotarget. 8:58405–58416. 2017.PubMed/NCBI
|
|
21
|
Yu J, Xu QG, Wang ZG, Yang Y, Zhang L, Ma
JZ, Sun SH, Yang F and Zhou WP: Circular RNA cSMARCA5 inhibits
growth and metastasis in hepatocellular carcinoma. J Hepatol.
68:1214–1227. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Enright AJ, John B, Gaul U, Tuschl T,
Sander C and Marks DS: MicroRNA targets in Drosophila. Genome Biol.
5:R12003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pasquinelli AE: MicroRNAs and their
targets: Recognition, regulation and an emerging reciprocal
relationship. Nat Rev Genet. 13:271–282. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xie Z, Hur SK, Zhao L, Abrams CS and
Bankaitis VA: A Golgi lipid signaling pathway controls apical Golgi
distribution and cell polarity during Neurogenesis. Dev Cell.
44:725–740. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sorber L, Zwaenepoel K, Jacobs J, De Winne
K, Goethals S, Reclusa P, Van Casteren K, Augustus E, Lardon F,
Roeyen G, et al: Circulating cell-free DNA and RNA analysis as
liquid biopsy: Optimal centrifugation protocol. Cancers (Basel).
11(pii): E 4582019. View Article : Google Scholar
|
|
29
|
Lu R, Shao Y, Ye G, Xiao B and Guo J: Low
expression of hsa_circ_0006633 in human gastric cancer and its
clinical significances. Tumor Biol. 39:1–7. 2017. View Article : Google Scholar
|
|
30
|
Bazan HA, Hatfield SA, Brug A, Brooks AJ,
Lightell DJ Jr and Woods TC: Carotid plaque rupture is accompanied
by an increase in the ratio of serum circR-284 to miR-221 levels.
Circ-Cardiovasc Gene. 10(pii): e00172042017.
|
|
31
|
Zhu Q, Lu G, Luo Z, Gui F, Wu J, Zhang D
and Ni Y: CircRNA circ_0067934 promotes tumor growth and metastasis
in hepatocellular carcinoma through regulation of
miR-1324/FZD5/Wnt/β-catenin axis. Biochem Bioph Res Co.
497:626–632. 2018. View Article : Google Scholar
|
|
32
|
Meng S, Zhou H, Feng Z, Xu Z, Tang Y, Li P
and Wu M: CircRNA: Functions and properties of a novel potential
biomarker for cancer. Mol Cancer. 16:94–102. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jiang G, Wen L, Deng W, Jian Z and Zheng
H: Regulatory role of miR-211-5p in hepatocellular carcinoma
metastasis by targeting ZEB2. Biomed Pharmacother. 90:806–812.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Quan J, Pan X, He T, Lin C and Lai Y, Chen
P, Zhang Z, Yang S, Wang T and Lai Y: Tumor suppressor miR-211-5p
is associated with cellular migration, proliferation and apoptosis
in renal cell carcinoma. Exp Ther Med. 15:4019–4028.
2018.PubMed/NCBI
|
|
35
|
Chen LL, Zhang ZJ, Yi ZB and Li JJ:
MicroRNA-211-5p suppresses tumour cell proliferation, invasion,
migration and metastasis in triple-negative breast cancer by
directly targeting SETBP1. Brit J Cancer. 117:78–88. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang L, Shen YF, Shi ZM, Shang XJ, Jin DL
and Xi F: Overexpression miR-211-5p hinders the proliferation,
migration, and invasion of thyroid tumor cells by downregulating
SOX11. J Clin Lab Anal. 32:2018. View Article : Google Scholar
|
|
37
|
Jiang G, Wen L, Zheng H, Jian Z and Deng
W: miR-204-5p targeting SIRT1 regulates hepatocellular carcinoma
progression. Cell Biochem Funct. 34:505–510. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gao W, Wu Y, He X, Zhang C, Zhu M, Chen B,
Liu Q, Qu X, Li W, Wen S and Wang B: MicroRNA-204-5p inhibits
invasion and metastasis of laryngeal squamous cell carcinoma by
suppressing forkhead box C1. J Cancer. 8:2356–2368. 2017.
View Article : Google Scholar : PubMed/NCBI
|
